ASCO applauds the California legislature for being the first state body of lawmakers in the nation to consider legislation that is designed to specifically improve clinical pathways in oncology. Clinical pathways, when appropriately designed and implemented, are evidence-based treatment management tools used to support delivery of high-quality cancer care for specific patient presentations.
ALEXANDRIA, Va. – Studies spanning the spectrum of cancer prevention and care, from immunotherapy and precision medicine to survivorship, will be highlighted in the official Press Program for the 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO). Research results will be released in advance of and throughout the Annual Meeting, taking place June 2-6 in Chicago.
The American Society of Clinical Oncology, Inc. (ASCO®) today issued recommendations addressing the needs of sexual and gender minority (SGM) populations as they relate to cancer. The recommendations, published in a policy statement in the Journal of Clinical Oncology, are designed to focus attention on the challenges facing the SGM community--including discrimination and greater risk of anxiety and depression, resulting in disparate care—and concrete steps that can help minimize health disparities among SGM individuals.
The American Society of Clinical Oncology (ASCO) has released a set of recommendations to enhance the role of observational cancer research in clinical decision-making. Published in the Journal of Clinical Oncology (JCO), the ASCO research statement discusses the expanding opportunities to utilize observational studies to advance cancer research and supplement the knowledge gained through cancer clinical trials.
WASHINGTON – The U.S. cancer care delivery system is undergoing profound changes to better meet the needs of people with cancer, but persistent hurdles threaten to slow progress, according to the American Society of Clinical Oncology’s (ASCO) fourth annual State of Cancer Care in America report released today.
We soundly oppose President Trump’s budget outline, which would cut $6 billion from the National Institutes of Health (NIH). Reducing NIH’s funding by nearly 20 percent will devastate our nation’s already fragile federal research infrastructure and undercut a longstanding commitment to biomedical science that has fueled advances in cancer prevention, diagnosis, and treatment.
ALEXANDRIA, Va. -- On March 22, 2017, the American Society of Clinical Oncology (ASCO) will release The State of Cancer Care in America: 2017 report, which examines the current landscape of the cancer care delivery system in the United States, and outlines key opportunities and challenges facing cancer care providers and patients today.
“The American Society of Clinical Oncology (ASCO) congratulates Seema Verma for her confirmation as Administrator of the Centers for Medicare & Medicaid Services (CMS). Administrator Verma is now in a key position to lead the agency during the next phase of healthcare reform in the United States, and to help ensure that millions of Medicare and Medicaid beneficiaries with cancer have access to high-quality oncology care."
ALEXANDRIA, Va. –– The embargo has lifted on all abstracts from the 2017 Quality Care Symposium. Journalists may now report on these abstracts, which are publicly available at ascopubs.org.
ALEXANDRIA, Va. – Researchers have found a link between microbes in the gut (the microbiome) and response to immunotherapy. In the study, the ability of patients with advanced melanoma to respond to PD-1 immune checkpoint inhibitors depended on the presence of a diverse microbiome as well as specific bacterial species. The study will be presented at the upcoming 2017 ASCO-SITC Clinical Immuno-Oncology Symposium in Orlando.
Chicago, Northfield, IL, Bethesda, MD, Alexandria, VA—A new, evidenced-based clinical practice guideline on molecular biomarker testing for patients with colorectal cancer identifies opportunities for improving patient outcomes.
ALEXANDRIA, Va. – A new analysis finds that 42% of partners of young breast cancer survivors experience anxiety, even several years after their partner’s cancer diagnosis. Researchers note that ineffective (maladaptive) coping strategies, parenting concerns, and other factors were associated with anxiety. The findings are part of a growing body of research on the effects of a cancer diagnosis on caregivers and family members, and reinforce the need for greater caregiver support, which has implications for their own, as well as survivors’ health and quality of life. The data will be presented as part of the upcoming 2017 Cancer Survivorship Symposium in San Diego.
Alexandria, Va. – The American Society of Clinical Oncology (ASCO) released, “ASCO Principles for Patient-Centered Healthcare Reform,” seven recommendations designed to ensure access to high-quality cancer care amid the changing U.S. healthcare delivery landscape. The principles aim to assist the new Congress and Administration, so, as they consider the critical underpinnings of any healthcare reform proposal, the needs of patients facing a cancer diagnosis are met.
Alexandria, Va. – CancerLinQ LLC, a nonprofit subsidiary of the American Society of Clinical Oncology® (ASCO), today announced CancerLinQ Discovery™, a groundbreaking offering that will provide insights through the analysis of real-world cancer care data. CancerLinQ Discovery will provide highly curated, de-identified sets of clinical data with the objective of creating new clinical knowledge and improving patient outcomes. It will derive these sets from the rapidly-growing CancerLinQ® database, which now includes over 1.5 million patient records and more than 70 oncology practices that have agreed to contribute data to CancerLinQ’s core quality improvement and data-sharing platform.